Inverse Planned High-Dose-Rate Brachytherapy for Locoregionally Advanced Cervical Cancer: 4-Year Outcomes

International Journal of Radiation Oncology Biology Physics

Volumn 92, Issue 5, 2015, Pages 1093-1100

  Tinkle, Christopher L ^a   Weinberg, Vivian ^a   Chen, Lee May ^b   Littell, Ramey ^c   Cunha, J Adam M ^a   Sethi, Rajni A ^a   Chan, John K ^d   Hsu, I Chow ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c KAISER PERMANENTE MEDICAL CENTER   (United States)

^d CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOTHERAPY; DIAGNOSIS; DISEASE CONTROL; DISEASES; INVERSE PROBLEMS; ONCOLOGY; PATHOLOGY; SIMULATED ANNEALING; TOXICITY;

COMMON TERMINOLOGY CRITERIA; CONCURRENT CISPLATIN; CONFIDENCE INTERVAL; DISEASE FREE SURVIVAL; HIGH-DOSE RATE BRACHYTHERAPY; KAPLAN-MEIER ESTIMATES; LOCOREGIONAL RECURRENCE; METHODS AND MATERIALS;

RADIOTHERAPY;

CISPLATIN;

ADULT; ADVANCED CANCER; AGED; BLOOD TOXICITY; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; CONFERENCE PAPER; CYSTITIS; DIARRHEA; DISEASE FREE SURVIVAL; DISTANT METASTASIS; FEBRILE NEUTROPENIA; FEMALE; FEVER; FOLLOW UP; GASTROINTESTINAL TOXICITY; HEMATURIA; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHOCELE; MAJOR CLINICAL STUDY; MIDDLE AGED; OVERALL SURVIVAL; PELVIS LYMPH NODE; PRIORITY JOURNAL; RECTUM HEMORRHAGE; RETROSPECTIVE STUDY; TREATMENT OUTCOME; UROGENITAL TRACT DISEASE; UTERINE CERVIX CANCER; VERY ELDERLY; ADENOCARCINOMA; ADVERSE EFFECTS; CARCINOMA, SQUAMOUS CELL; COHORT ANALYSIS; COMPUTER ASSISTED RADIOTHERAPY; CONFIDENCE INTERVAL; IMAGE GUIDED RADIOTHERAPY; KAPLAN MEIER METHOD; MORTALITY; ORGANS AT RISK; PATHOLOGY; PROCEDURES; RADIATION DOSE; RADIATION INJURY; RADIATION RESPONSE; RADIOGRAPHY; TIME; TUMOR RECURRENCE; TUMOR VOLUME; UTERINE CERVICAL NEOPLASMS;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BRACHYTHERAPY; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; CONFIDENCE INTERVALS; DISEASE-FREE SURVIVAL; FEMALE; HEMATURIA; HUMANS; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; ORGANS AT RISK; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, IMAGE-GUIDED; RETROSPECTIVE STUDIES; TIME FACTORS; TUMOR BURDEN; UTERINE CERVICAL NEOPLASMS;

EID: 84937501032     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2015.04.018     Document Type: Conference Paper

References (46)

1. M. Morris, P.J. Eifel, J. Lu, and et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer N Engl J Med 340 1999 1137 1143
2. P.J. Eifel, K. Winter, M. Morris, and et al. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: An update of Radiation Therapy Oncology Group trial (RTOG) 90-01 J Clin Oncol 22 2004 872 880
3. H.M. Keys, B.N. Bundy, F.B. Stehman, and et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma N Engl J Med 340 1999 1154 1161
4. C.W. Whitney, W. Sause, B.N. Bundy, and et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: A Gynecologic Oncology Group and Southwest Oncology Group study J Clin Oncol 17 1999 1339 1348
5. W.A. Peters 3rd, P.Y. Liu, R.J. Barrett 2nd, and et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix J Clin Oncol 18 2000 1606 1613
6. P.G. Rose, S. Ali, E. Watkins, and et al. Long-term follow-up of a randomized trial comparing concurrent single agent cisplatin, cisplatin-based combination chemotherapy, or hydroxyurea during pelvic irradiation for locally advanced cervical cancer: A Gynecologic Oncology Group Study J Clin Oncol 25 2007 2804 2810
7. Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: A systematic review and meta-analysis of individual patient data from 18 randomized trials J Clin Oncol 26 2008 5802 5812
8. R.M. Lanciano, M. Won, L.R. Coia, and et al. Pretreatment and treatment factors associated with improved outcome in squamous cell carcinoma of the uterine cervix: A final report of the 1973 and 1978 patterns of care studies Int J Radiat Oncol Biol Phys 20 1991 667 676
9. G.S. Montana, A.L. Hanlon, T.J. Brickner, and et al. Carcinoma of the cervix: Patterns of care studies: Review of 1978, 1983, and 1988-1989 surveys Int J Radiat Oncol Biol Phys 32 1995 1481 1486
10. D.J. Brenner, Y. Huang, and E.J. Hall Fractionated high dose-rate versus low dose-rate regimens for intracavitary brachytherapy of the cervix: Equivalent regimens for combined brachytherapy and external irradiation Int J Radiat Oncol Biol Phys 21 1991 1415 1423
11. T. Teshima, T. Inoue, H. Ikeda, and et al. High-dose rate and low-dose rate intracavitary therapy for carcinoma of the uterine cervix: Final results of Osaka University Hospital Cancer 72 1993 2409 2414
12. D.G. Petereit, J.N. Sarkaria, D.M. Potter, and et al. High-dose-rate versus low-dose-rate brachytherapy in the treatment of cervical cancer: Analysis of tumor recurrence-The University of Wisconsin experience Int J Radiat Oncol Biol Phys 45 1999 1267 1274
13. M. Hareyama, K. Sakata, A. Oouchi, and et al. High-dose-rate versus low-dose-rate intracavitary therapy for carcinoma of the uterine cervix: A randomized trial Cancer 94 2002 117 124
14. P. Lertsanguansinchai, C. Lertbutsayanukul, K. Shotelersuk, and et al. Phase III randomized trial comparing LDR and HDR brachytherapy in treatment of cervical carcinoma Int J Radiat Oncol Biol Phys 59 2004 1424 1431
15. X. Wang, R. Liu, B. Ma, and et al. High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancer Cochrane Database Syst Rev 7 2010 CD007563
16. F.D. Patel, S.C. Sharma, P.S. Negi, and et al. Low dose rate vs. high dose rate brachytherapy in the treatment of carcinoma of the uterine cervix: A clinical trial Int J Radiat Oncol Biol Phys 28 1994 335 341
17. E. Chajon, I. Dumas, M. Touleimat, and et al. Inverse planning approach for 3-D MRI-based pulse-dose rate intracavitary brachytherapy in cervix cancer Int J Radiat Oncol Biol Phys 69 2007 955 961
18. S. Nag, H. Cardenes, S. Chang, and et al. Proposed guidelines for image-based intracavitary brachytherapy for cervical carcinoma: Report from Image-Guided Brachytherapy Working Group Int J Radiat Oncol Biol Phys 60 2004 1160 1172
19. R. Potter, C. Haie-Meder, E. Van Limbergen, and et al. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): Concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology Radiother Oncol 78 2006 67 77
20. A.N. Viswanathan, S. Beriwal, J.F. De Los Santos, and et al. American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part II: High-dose-rate brachytherapy Brachytherapy 11 2012 47 52
21. E. Lessard, I.C. Hsu, and J. Pouliot Inverse planning for interstitial gynecologic template brachytherapy: Truly anatomy-based planning Int J Radiat Oncol Biol Phys 54 2002 1243 1251
22. S. Kirkpatrick, C.D. Gelatt Jr., and M.P. Vecchi Optimization by simulated annealing Science 220 1983 671 680
23. C. Menard, R.C. Susil, P. Choyke, and et al. MRI-guided HDR prostate brachytherapy in standard 1.5T scanner Int J Radiat Oncol Biol Phys 59 2004 1414 1423
24. S.V. Jamema, S. Sharma, U. Mahantshetty, and et al. Comparison of IPSA with dose-point optimization and manual optimization for interstitial template brachytherapy for gynecologic cancers Brachytherapy 10 2011 306 312
25. D.H. Kim, A. Wang-Chesebro, V. Weinberg, and et al. High-dose rate brachytherapy using inverse planning simulated annealing for locoregionally advanced cervical cancer: A clinical report with 2-year follow-up Int J Radiat Oncol Biol Phys 75 2009 1329 1334
26. S. Pecorelli, L. Zigliani, and F. Odicino Revised FIGO staging for carcinoma of the cervix Int J Gynaecol Obstet 105 2009 107 108
27. S.B. Edge, and C.C. Compton The American Joint Committee on Cancer: The 7th edition of the AJCC cancer staging manual and the future of TNM Ann Surg Oncol 17 2010 1471 1474
28. K.D. Dewitt, I.C. Hsu, J. Speight, and et al. 3D inverse treatment planning for the tandem and ovoid applicator in cervical cancer Int J Radiat Oncol Biol Phys 63 2005 1270 1274
29. C.D. Kubicky, B.M. Yeh, E. Lessard, and et al. Inverse planning simulated annealing for magnetic resonance imaging-based intracavitary high-dose-rate brachytherapy for cervical cancer Brachytherapy 7 2008 242 247
30. C. Haie-Meder, R. Potter, E. Van Limbergen, and et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): Concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV Radiother Oncol 74 2005 235 245
31. L. Moureau-Zabotto, L. Thomas, B.N. Bui, and et al. Management of soft tissue sarcomas (STS) in first isolated local recurrence: A retrospective study of 83 cases Radiother Oncol 73 2004 313 319
32. A.N. Viswanathan, J. Dimopoulos, C. Kirisits, and et al. Computed tomography versus magnetic resonance imaging-based contouring in cervical cancer brachytherapy: Results of a prospective trial and preliminary guidelines for standardized contours Int J Radiat Oncol Biol Phys 68 2007 491 498
33. S. Van Dyk, K. Narayan, R. Fisher, and et al. Conformal brachytherapy planning for cervical cancer using transabdominal ultrasound Int J Radiat Oncol Biol Phys 75 2009 64 70
34. D. Zwahlen, J. Jezioranski, P. Chan, and et al. Magnetic resonance imaging-guided intracavitary brachytherapy for cancer of the cervix Int J Radiat Oncol Biol Phys 74 2009 1157 1164
35. K. Tanderup, S.K. Nielsen, G.B. Nyvang, and et al. From point A to the sculpted pear: MR image guidance significantly improves tumour dose and sparing of organs at risk in brachytherapy of cervical cancer Radiother Oncol 94 2010 173 180
36. P. Trnkova, R. Potter, D. Baltas, and et al. New inverse planning technology for image-guided cervical cancer brachytherapy: Description and evaluation within a clinical frame Radiother Oncol 93 2009 331 340
37. S.V. Jamema, C. Kirisits, U. Mahantshetty, and et al. Comparison of DVH parameters and loading patterns of standard loading, manual and inverse optimization for intracavitary brachytherapy on a subset of tandem/ovoid cases Radiother Oncol 97 2010 501 506
38. R. Potter, P. Georg, J.C. Dimopoulos, and et al. Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer Radiother Oncol 100 2011 116 123
39. A. Hallock, K. Surry, D. Batchelar, and et al. An early report on outcomes from computed tomographic-based high-dose-rate brachytherapy for locally advanced cervix cancer: A single institution experience Pract Radiat Oncol 1 2011 173 181
40. K. Narayan, S. van Dyk, D. Bernshaw, and et al. Ultrasound guided conformal brachytherapy of cervix cancer: Survival, patterns of failure, and late complications J Gynecol Oncol 25 2014 206 213
41. C. Charra-Brunaud, V. Harter, M. Delannes, and et al. Impact of 3D image-based PDR brachytherapy on outcome of patients treated for cervix carcinoma in France: Results of the French STIC prospective study Radiother Oncol 103 2012 305 313
42. P.W. Grigsby, C.A. Perez, K.S. Chao, and et al. Radiation therapy for carcinoma of the cervix with biopsy-proven positive para-aortic lymph nodes Int J Radiat Oncol Biol Phys 49 2001 733 738
43. A. Duenas-Gonzalez, J.J. Zarba, F. Patel, and et al. Phase III, open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplatin and radiation in patients with stage IIB to IVA carcinoma of the cervix J Clin Oncol 29 2011 1678 1685
44. A phase III trial of adjuvant chemotherapy following chemoradiation as primary treatment for locally advanced cervical cancer compared to chemoradiation alone: Outback (ANZGOG0902/GOG0274/RTOG1174). Available at: http://clinicaltrials.gov/show/NCT01414608. Accessed August 15, 2014.
45. T.E. Schefter, K. Winter, J.S. Kwon, and et al. A phase II study of bevacizumab in combination with definitive radiotherapy and cisplatin chemotherapy in untreated patients with locally advanced cervical carcinoma: Preliminary results of RTOG 0417 Int J Radiat Oncol Biol Phys 83 2012 1179 1184
46. M.P. Schmid, M. Franckena, K. Kirchheiner, and et al. Distant metastasis in patients with cervical cancer after primary radiotherapy with or without chemotherapy and image guided adaptive brachytherapy Gynecol Oncol 133 2014 256 262